Thyquidity

Azurity Pharmaceuticals is a privately held specialty pharmaceutical company focused on developing and commercializing innovative products that address the specific needs of underserved patient populations, particularly in pediatrics and geriatrics. The company specializes in creating liquid formulations of established medications to improve dosing accuracy and ease of administration for patients who have difficulty swallowing tablets. One of its key products is Thyquidity (levothyroxine sodium) oral solution, which is indicated for the treatment of hypothyroidism and the suppression of pituitary thyrotropin-stimulating hormone. Azurity's portfolio spans several therapeutic areas including endocrinology, neurology, cardiovascular, and gastrointestinal health.